Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy
Florence van Tienen(Maastricht University Medical Centre), Hubert J.M. Smeets(Maastricht University), Mattia Quattrocelli(Cincinnati Children's Hospital Medical Center), Maurilio Sampaolesi(Sapienza University of Rome), I.F.M. de Coo(Maastricht University), Erika Timmer(Maastricht University Medical Centre), Elvira Mulder-den Hartog(Erasmus MC), Patrick Lindsey(Maastricht University Medical Centre), Ruby Zelissen(Maastricht University Medical Centre)
Cited by 23
Related Papers
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
|Cancer Cell|2005|1.3k
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells
|Nature Cell Biology|2007|979
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts
|Science|2003|620
X-linked Alport Syndrome
|Journal of the American Society of Nephrology|2000|592